Article Text

Download PDFPDF

Gamna-Gandy nodules of the spleen and asplenism in SLE: a novel association?
Free
  1. Annefleur J Petri1,
  2. Maarten Limper2,
  3. Anya Milne3,
  4. Lenneke E M Haas4
  1. 1Anesthesiology, VU Medisch Centrum, Amsterdam, The Netherlands
  2. 2Internal Medicine and Dermatology, Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands
  3. 3Pathology, Diakonessenhuis Utrecht, Utrecht, The Netherlands
  4. 4Intensive Care, Diakonessenhuis Utrecht, Utrecht, The Netherlands
  1. Correspondence to Lenneke E M Haas, lvlelyveld{at}diakhuis.nl

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

We present a case of a 53-year-old woman who presented to the emergency room with acute abdominal pain, fever and haemodynamic and respiratory instability and was admitted to the intensive care unit with fulminant septic shock with multiorgan failure. CT imaging of the abdomen showed no gross abnormalities, initial laboratory results are presented in table 1.

Table 1

Laboratory test results

Despite adequate resuscitation, broad-spectrum antibiotics and supportive care, following the International Guidelines of the Surviving Sepsis Campaign, she died within a couple of hours. The patient had a history of systemic lupus erythematosus (SLE) with arthralgia, positive antinuclear antibodies and persistently high anti-DNA antibodies, but without active disease and no immunosuppressive medication since years.

Leucocyte typing of the initial peripheral blood smear showed Howell-Jolly bodies and diplococci, indicating massive bacterial load and functional asplenism. Functional asplenism or hyposplenism is present in up to 5% of patients with SLE with or without disease activity before.1 No thrombocytosis or antiphospholipid antibodies—that are suggested as clues to autosplenectomy—were found in our patient.2

Postmortem blood cultures became positive for Streptococcus pneumonia. Pathology revealed perivascular infiltrates in the liver and Gamna-Gandy bodies (GGB) in a remarkably small spleen (figure 1).

Figure 1

Microscopy of the spleen (HE ×25), revealing Gamna-Gandy nodules (centre).

The%20patient did not take medication or drugs that could explain this image of the liver. GGB or haemosiderotic nodules are foci of haemosiderin deposition resulting from intrasplenic haemorrhage (figure 2 and figure 3). Portal hypertension is considered the primary cause of GGBs and their appearance is associated with sickle-cell anaemia, hereditary haemochromatosis, haemolytic anaemia, acquired haemosiderosis, paroxysmal nocturnal haemoglobinuria, portal or splenic vein thrombosis, leukaemia, lymphoma and repeated blood transfusion.3 However, these conditions known to be associated with GGB were absent in our patient.

Figure 2

High-power view (HE ×200) of the Gamna-Gandy bodies. These rust-coloured foci contained fibrous tissue with haemosiderin deposits, and probably form due to scarring at sites of small perivascular haemorrhages.

Figure 3

Prussian blue stain showing iron deposition (blue) in the Gamna-Gandy bodies.

Although the pathophysiological processes leading to hyposplenism in SLE remain largely unknown, it has been proposed that this is a result of silent infarction due to hyposplenism.4 As a consequence of inflammatory microvessel damage, splenic haemosiderin depositions may occur and remain visible, also after the resolution of vasculitis. Furthermore, despite the absence of antiphospholipid antibodies in this patient, splenic microangiopathy and microthrombosis associated with SLE may have contributed to ‘leaky’ splenic microvasculature, resulting in GGBs and partial autosplenectomy as described above.

In conclusion, this case once again illustrates the association of SLE with asplenism and the fulminant course of pneumococcal sepsis in those patients,5 despite disease inactivity for years. Moreover, GGB were found, which could not be related to known associated diseases. As far as we know, this is the first case describing GGB in a patient with SLE and functional asplenism.

Learning points

  • Functional asplenism or hyposplenism is present in a small but significant part of patients with systemic lupus erythematosus (SLE), regardless of disease activity and use of immunosuppressive medication. Diagnostic clues indicating a susceptibility to splenic hypofunction or dysfunction remain uncertain, making it impossible to predict which patients will develop asplenism.

  • Taking into account the fulminant course of pneumococcal infection in patients with SLE and asplenism, prophylactic vaccination should be considered in every patient with SLE.4 5

  • This is the first case that describes GGB in a patient with SLE and functional asplenism.

References

View Abstract

Footnotes

  • Contributors LEMH and AJP: contributed equally to the writing of this manuscript and were personally involved with the case. AM: provided the pathology images and wrote the figure captions. ML: shared his expertise on the subject in trying to explain the findings in this particular setting. AM and ML: reviewed the draft text.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.